ANTIMYKOTISCHE POLYPEPTIDE

European patent · EP4125379 · In force

Register entry

Publication number
EP4125379
Application number
EP21715638
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 31, 2021
Published
Feb 8, 2023
Granted
Aug 21, 2024
Protection ends at the latest
Mar 30, 2041
Next annual fee due
Mar 31, 2027
IPC classes
A01N 37/46 (2006.01)
A01N 63/10 (2020.01)
A01N 63/50 (2020.01)
A61P 31/10 (2006.01)
C07K 16/14 (2006.01)
C12N 15/82 (2006.01)
Priority
EP 20167432 31.03.2020
EP 20218017 31.12.2020
PCT application
PCT/EP2021/058548 31.03.2021
PCT publication
WO2021/198396 07.10.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Jul 2, 2025

    Change

    Published in Swissreg on 02.07.2025

  3. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  4. Oct 11, 2024

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 11.10.2024

  5. Aug 21, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.08.2024

Parties

Holder

Biotalys NV

Buchtenstraat 11, 9051 Gent, BE

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

STANSSENS, Patrick

9052 Gent, BE

VAN DAELE, Inge Elodie

9052 Gent, BE

REVETS, Hilde Adi Pierrette

9052 Gent, BE

BELOGLAZOVA, Natalia

9052 Gent, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.